Novel device successfully treats central sleep apnea in heart failure

Implantable system improves sleep and heart function with no mask required

2014-05-19

(Press-News.org) Athens, 19 May 2014: A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. The one year results of the remede® system pilot study were revealed for the first time by lead author Professor William T. Abraham from the Ohio State University. He said: "The remede® system is the first fully implantable device to treat central sleep apnoea in heart failure patients. Unlike traditional mask based therapies – which have been shown to work only in some patients under certain conditions in CSA – the remede® system is acceptable to patients and improves their sleep and heart function."

He added: "Patients using the device tell us they haven't slept so well in years. They have more energy and can do their normal daily activities without falling asleep. They also don't have to fight with a mask."

CSA is a comorbidity in approximately 35% of heart failure patients and doubles the risk of death. Until now there was no proven treatment. The remede® system uses unilateral transvenous phrenic nerve stimulation to prevent CSA before it occurs. The pulse generator is implanted under the skin like a pacemaker, just below the collar bone, and a wire is threaded into one of the veins near the phrenic nerve.

Professor Abraham said: "The device stimulates the diaphragm via the phrenic nerve, causing the diaphragm to contract. It regularises the patient's breathing pattern throughout the night, rather than waiting until the patient stops breathing to react."

The remede® system pilot study was a prospective, multicentre trial in 46 patients with moderate to severe CSA who were implanted with the remede® system. The primary endpoint was a reduction in apnoea hypopnea index (AHI) at three months compared to baseline with six and 12 month data also collected.

The one year results, revealed today, show that the remede® system led to substantial benefits in sleep parameters including a reduction in AHI, a reduction in the time spent with low blood oxygen levels overnight, and improvements in sleep efficiency and REM sleep.

The remede® system also improved important cardiac endpoints such as heart rate variability, which is a measure of autonomic balance. Patients were less sleepy and their quality of life improved, according to the Minnesota Living with Heart Failure Quality of Life questionnaire.

Professor Abraham said: "Patients with the remede® system feel better, they are less symptomatic, their quality of life is improved, and the underlying mechanisms that lead to heart failure progression such as autonomic imbalance are improved."

Favourable effects on the structure and function of the heart, called reversed remodelling, were also demonstrated. In patients with the implantable device, the heart got smaller, the left ventricular diastolic volume decreased significantly and the heart became stronger, with significant improvements in left ventricular ejection fraction. Professor Abraham said: "These are changes that generally correlate with improvement in long term clinical outcomes."

He continued: "The major problem with mask based therapies such as continuous positive airway pressure (CPAP) is patient acceptance and compliance. Up to 50% of patients can't or won't wear a mask so their sleep apnoea is untreated or inadequately treated."

Professor Abraham concluded: "All heart failure patients should be screened for sleep apnoea and those with OSA should be offered a mask based therapy. Patients with CSA are good candidates for the remede® system which can improve their sleepiness, quality of life and potentially their clinical outcomes."

The pivotal trial for US regulatory approval is ongoing and is set to enroll around 150 patients in the US and Europe. Results are expected by the end of 2015.

INFORMATION: Notes to editor

About the European Society of Cardiology The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

About the Heart Failure Association (HFA) The Heart Failure Association (HFA) is a registered branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.

For practical information about heart failure aimed at patients, families and caregivers, visit the HFA's Heart Failure Matters website.

Did you want to tweet about our congress? - if you do, please use the official #heartfailure2014 hashtag! Thank you

Information for journalists attending Heart Failure 2014

If you have any question or request regarding interview opportunities, please contact: ESC Press Office
Jacqueline Partarrieu
press@escardio.org
Tel: +33 6 22 83 45 76 (off site support number)

Heart Failure 2014 takes place in Athens, Greece, on 17-20 May 2014 at the MAICC Congress Center.

Look here for the current final programme: http://www.escardio.org/congresses/heart-failure-2014/Documents/fp-hf2014-web.pdf?hit=highlight-on

For full details of a session, have a look at the Scientific Programme & Planner: http://spo.escardio.org/default.aspx?eevtid=68&showResults=False

On-site Press registration process: Free registration applies to press representatives upon receipt of valid credentials and a fully completed embargo form. Credential: either your ID press card or letter of assignment with proof of 3 published articles Press registration is not available to Industry or its Public Relations representatives, event management, marketing or communications representatives The decision of the ESC Press Office is final regarding all press registration requests. When your registration as press will be validated you will be given a press badge and the press kit. The press working area is located in front of the registration desks. It features free wifi and a printer linked to a computer.

ELSE PRESS RELEASES FROM THIS DATE:

Solution to helping teens with chronic disease may be at fingertips

2014-05-19

Adolescents with chronic diseases (ACD), such as cystic fibrosis, gastrointestinal disorders (including Crohn's disease) and Type 1 diabetes, often find the transition of managing their health care needs into adulthood to be challenging. Preparations for this transition are often clinic-based, costly and do not fully or effectively engage with this patient population. A new study by researchers at the University of California, San Diego School of Medicine found the answer to developing independent, self-management skills in ACD could be right at the patient's fingertips. ...

Chronic insufficient sleep increases obesity, overall body fat in children

2014-05-19

One of the most comprehensive studies of the potential link between reduced sleep and childhood obesity finds compelling evidence that children who consistently received less than the recommended hours of sleep during infancy and early childhood had increases in both obesity and in adiposity or overall body fat at age 7. The study from MassGeneral Hospital for Children (MGHfC) investigators, published in the June issue of Pediatrics, also finds no evidence of a specific period during which insufficient sleep has greater influence on later obesity. "Our study found convincing ...

Low risk prostate cancer not always low risk

2014-05-19

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California. However, according to a new UCLA study, selection of men for active surveillance should be based not on the widely used conventional biopsy, but with a new, image-guided targeted ...

Low-income Latino children show benefits from Montessori pre-kindergartern programs study finds

2014-05-19

WASHINGTON - Low-income Latino children who experienced one year of Montessori pre-K education at age 4 made dramatic improvements in early achievement and behavior even though they began the year at great risk for school failure, according to research published by the American Psychological Association. In contrast, although low-income black children made gains in school readiness when enrolled in Montessori classrooms as well, they exhibited slightly greater gains when they attended more conventional public school pre-kindergarten programs. The research was published ...

Shorter lives for male fruit flies forced to compete

2014-05-19

LIVERPOOL, UK – 9 May 2014: A University of Liverpool study of fruit flies has revealed that males forced to compete with other males become less attractive to females and die young. In the test, male fruit flies of the species Drosophila subobscura were kept either alone or in groups. The females of this species are monandrous – they only mate once in their lives, meaning that males have to get very lucky to mate at all. As a result males compete furiously for access to females. Evolutionary biologist, Dr Anne Lizé, who led the study said: "When we see stags fighting ...

One small chip -- one giant leap forward for early cancer detection

2014-05-19

Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It would be like putting a fire out while it was still just a few sparks versus after having already caught on and spread to many areas of the house. An international team of researchers, led by ICFO- Institute of Photonic Sciences in Castelldefels, announce ...

Study finds limited benefit for vitamin D in asthma treatment

2014-05-19

Adding vitamin D to asthma treatment to improve breathing only appears to benefit patients who achieve sufficient levels of the supplement in the blood. Overall, the ability to control asthma did not differ between a study group that received vitamin D supplements and a group that received placebo, according to new research at Washington University School of Medicine in St. Louis. "Previous studies suggested that if you have asthma and low levels of vitamin D in the blood, you have worse lung function, more asthma attacks and more emergency room visits than asthma patients ...

Illuminating neuron activity in 3-D

2014-05-18

Researchers at MIT and the University of Vienna have created an imaging system that reveals neural activity throughout the brains of living animals. This technique, the first that can generate 3-D movies of entire brains at the millisecond timescale, could help scientists discover how neuronal networks process sensory information and generate behavior. The team used the new system to simultaneously image the activity of every neuron in the worm Caenorhabditis elegans, as well as the entire brain of a zebrafish larva, offering a more complete picture of nervous system ...

Team validates potentially powerful new way to treat HER2-positive breast cancer

2014-05-18

Cold Spring Harbor, NY -- Scientists at Cold Spring Harbor Laboratory (CSHL) today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer. The breast cancer subtype in question is commonly called "HER2-positive"; it's a subset of the disease affecting about one patient in four, in which tumor cells overexpress a signaling protein called HER2. The blockbuster drug Herceptin is a treatment of choice for many women with HER2-positive breast cancer, but in most cases, resistance to the treatment ...

COPD patients at significantly higher risk of heart failure

2014-05-18

ATS 2014, SAN DIEGO ─ As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure. That's according to a new study from the Morehouse School of Medicine in Atlanta, which found the prevalence of heart failure is significantly higher in patients with COPD compared to the rest of the study population. They also found that the risk was especially high among African-American patients ...

LAST 30 PRESS RELEASES:

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology